Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging, and biochemical findings

Nicola Lautenschlager, M. Riemenschneider, A. Drzezga, A. Kurz

    Research output: Contribution to journalArticlepeer-review

    46 Citations (Scopus)

    Abstract

    Mild cognitive impairment (MCI) is a heterogeneous clinical syndrome for which no international diagnostic criteria have yet been established. Longitudinal studies have shown that many individuals who later develop dementia pass through a stage of MCI. We are following up 36 individuals who were initially diagnosed as having the memory-impaired primary degenerative type of MCI and therefore are at high risk of developing Alzheimer's disease. Clinical, neuropsychological, brain imaging and CSF biochemical markers were examined. Findings were remarkably heterogeneous even in this highly selected group of patients. This suggests that MCI is aetiologically not uniform. Copyright (C) 2001 S. Karger AG, Basel.
    Original languageEnglish
    Pages (from-to)379-386
    JournalDementia and Geriatric Cognitive Disorders
    Volume12
    DOIs
    Publication statusPublished - 2001

    Fingerprint

    Dive into the research topics of 'Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging, and biochemical findings'. Together they form a unique fingerprint.

    Cite this